Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma Journal Article

   

Authors:	Shen, S.; Rubinstein, M. M.; Park, K. J.; Konner, J. A.; Makker, V.
Article Title:	Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
Keywords:	kras; endometrial; lenvatinib; pembrolizumab; mesonephric; mesonephric-like
Journal Title:	Gynecologic Oncology Reports
Volume:	37
ISSN:	2352-5789
Publisher:	Elsevier B.V.
Date Published:	2021-08-01
Start Page:	100844
Language:	English
DOI:	10.1016/j.gore.2021.100844
PROVIDER:	scopus
PMCID:	PMC8365456
PUBMED:	34430690
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112475528&doi=10.1016%2fj.gore.2021.100844&partnerID=40&md5=7a267a6d4b5663c70c70ddfeb0ca2d65
Notes:	Article -- Export Date: 1 September 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/185974